Advocacy intelligence hub — real-time data for patient organizations
ECOG-ACRIN Cancer Research Group — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Cimetidine
(CIMETIDINE)Orphan drugstandardChartwell RX, LLC
Histamine-2 Receptor Antagonist [EPC]
James Yao
M.D. Anderson Cancer Center
Timothy Hobday, M.D
Mayo Clinic
📍 ROCHESTER, MN
Pamela Kunz, M.D
ECOG-ACRIN Cancer Research Group
📍 NEW HAVEN, CT
Nexium Medical Science Director, MD
AstraZeneca
Matthew H Kulke, MD
Alliance for Clinical Trials in Oncology
📍 SOUTH PORTLAND, ME
Henry Pitot, M.D
Mayo Clinic
📍 ROCHESTER, MN